Publication | Closed Access

High-order TRAIL oligomer formation in TRAIL-coated lipid nanoparticles enhances DR5 cross-linking and increases antitumour effect against colon cancer

NanomedicineNanotherapeuticsEngineeringPolymer-drug ConjugateMedicineNano-drug DeliveryTumor TargetingColon CancerPharmacologyRadiation OncologyAntitumour EffectBiomolecular Engineering